Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anica Hoegner (Anica Högner)

Years Active: 2021-2022
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Alexej Ballhausen, Prisca Bartels, Ines Iacovella, Anica Hoegner, Alessandro Lorusso, Dmitry Bichev, Severin Daum, Peter Thuss-Patience
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy. Current oncology (Toronto, Ont.) 29 (3) (2022)
Alessandro Lorusso, Dmitry Bichev, Anica Hoegner, Prisca Bartels, Alexej Ballhausen, Christoph Treese, Matthias Biebl, Peter Thuss-Patience
Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours. Current oncology (Toronto, Ont.) 29 (4) (2022)
Anica Hoegner, Markus Möhler
Immunotherapy in Gastric Cancer. Current oncology (Toronto, Ont.) 29 (3) (2022)
Anica Hoegner, Peter Thuss-Patience
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Anica Hoegner, Salah-Eddin Al-Batran, Jens T Siveke, Mario Lorenz, Prisca Bartels, Kirstin Breithaupt, Peter Malfertheiner, Nils Homann, Alexander Stein, Dietrich Gläser, Ingo Tamm, Axel Hinke, Arndt Vogel, Peter Thuss-Patience, null null
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510. International journal of cancer (2021)

Anica Hoegner.css-eqlu8i{font-size:small;padding-left:4px;} (Anica Högner)